By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Attune Pharma 

250 West 55th Street
Suite 16B
New York  New York  10019  U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS

Attune Pharmaceuticals is a pre-clinical stage biotechnology focused on the discovery and development of novel oral once-daily small molecule therapeutics for treatment of rare diseases. Attune Pharmaceuticals is currently developing 2 programs in rare diseases: Hereditary angioedema (HAE) and complement-mediated diseases. Attune Pharmaceuticals has identified ATN-249 as a lead candidate to treat HAE and will begin clinical testing in 2017.

LEADERSHIP:

CEO: Andrew McDonald

CMO: Ira N. Kalfus

CLINICAL TRIAL:

Please click here for clinical trial information.


Key Statistics


Email: info@attunepharma.com
Ownership: Private

Web Site: Attune
Employees:
Symbol: 
 



Industry
Pharmaceutical






Company News
//-->